← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Novab, Inc.
Atlanta, GA
$1,216,917
Total funding
6
Grants
Funding over time
peak $302K · FY2014–23$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,216,917 · 6
By mechanism
R43$1,080,751 · 5
R41$136,166 · 1
Investigators at Novab, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel targeted CAR-T multiple myeloma therapy$301,956
R43 · FY2023 · CA
Novel antibody polymer reagents for SARS-CoV-2 detection$256,506
R43 · FY2021 · AI
Monoclonal antibodies specific for biologically relevant glycans$223,366
R43 · FY2019 · GM
Humanization of VLR antibodies for therapeutic applications$149,887
R43 · FY2015 · CA
VLR-CART Cancer Immunotherapy$149,036
R43 · FY2014 · CA
Monoclonal lamprey VLR antibodies specific for mucin-type O-linked glycan core 1 - 4 structures$136,166
R41 · FY2017 · GM